Quantcast
Channel: cafepharma - solid tumors
Browsing latest articles
Browse All 16 View Live
↧

CytRx initiates Phase 1b trial with combination Aldoxorubicin, Doxorubicin

CytRx initiates Phase 1b trial with combination Aldoxorubicin, Doxorubicin The Fly on the Wall

View Article


Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at...

Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012 Yahoo/BusinessWire

View Article

Innate Pharma: Phase I Clinical Trial of IPH2102/BMS-986015 in Combination...

Innate Pharma: Phase I Clinical Trial of IPH2102/BMS-986015 in Combination With Ipilimumab Announced Yahoo

View Article

Northwest Biotherapeutics: An Example Of Reform In The Drug Approval Process

Northwest Biotherapeutics: An Example Of Reform In The Drug Approval Process Seeking Alpha

View Article

Illumina Launches TruSightâ„¢ Tumor Content Set

Illumina Launches TruSightâ„¢ Tumor Content Set Yahoo

View Article


BioMarin abstract showed impressive anti-tumor activity, says Leerink

BioMarin abstract showed impressive anti-tumor activity, says Leerink Yahoo/Fly on the Wall

View Article

3 Small Cap Cancer Stocks With Upcoming Catalysts

3 Small Cap Cancer Stocks With Upcoming Catalysts Seeking Alpha

View Article

CytRx announces data from Phase 1b trial of aldoxorubicin

CytRx announces data from Phase 1b trial of aldoxorubicin Yahoo/Fly on the Wall

View Article


Immunomedics Advances Solid Tumor Antibody-Drug Conjugate Programs to Phase...

Immunomedics Advances Solid Tumor Antibody-Drug Conjugate Programs to Phase II Clinical Trials Yahoo

View Article


Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors...

Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and Schedule Yahoo/BusinessWire

View Article

OncoMed Pharmaceuticals Presents Updated Phase 1a Data in Advanced Solid...

OncoMed Pharmaceuticals Presents Updated Phase 1a Data in Advanced Solid Tumor Patients for the First-in-Class WNT-Pathway-Targeting Antibody Vantictumab (OMP-18R5) at the European Cancer Congress 2013...

View Article

Five Data Presentations on BioMarin's BMN 673 PARP Inhibitor at the 2013...

Five Data Presentations on BioMarin's BMN 673 PARP Inhibitor at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Yahoo/Globe Newswire

View Article

Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan

Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan Yahoo/

View Article


Baxter, Cell Therapeutics announce collaboration to develop pacritinib

Baxter, Cell Therapeutics announce collaboration to develop pacritinib Yahoo/Fly on the Wall

View Article

If Northwest Biotherapeutics Wins, It Wins Big

If Northwest Biotherapeutics Wins, It Wins Big Seeking Alpha

View Article


Curis Re-Initiates Dosing for CUDC-427

Curis Re-Initiates Dosing for CUDC-427 Yahoo/Zacks

View Article
Browsing latest articles
Browse All 16 View Live